8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-20-007252
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading a8-kmay2020annualsharehold.htm…